TY - JOUR
T1 - Tobacco smoke and risk of childhood acute lymphoblastic leukemia
T2 - Findings from the SETIL case-control study
AU - Farioli, Andrea
AU - Legittimo, Patrizia
AU - Mattioli, Stefano
AU - Miligi, Lucia
AU - Benvenuti, Alessandra
AU - Ranucci, Alessandra
AU - Salvan, Alberto
AU - Rondelli, Roberto
AU - Conter, Valentino
AU - Magnani, Corrado
N1 - Funding Information:
Acknowledgments The SETIL study was financially supported by research grants received by AIRC (Italian Association on Research on Cancer), MIUR (Ministry for Instruction, University and Research, PRIN Program), Ministry of Health (Ricerca Sanitaria Finalizzata Program), Ministry of Labour and Welfare, Associazione Neuroblastoma, Piemonte Region (Ricerca Sanitaria Finalizzata Regione Piemonte Program), Liguria Region, Comitato per la vita ‘‘Daniele Chianelli’’-Associazione per la Ricerca e la Cura delle Leucemie, Linfomi e Tumori di Adulti e Bambini (Perugia). Andrea Farioli’s work on this paper was supported by the Master in Epidemiology, University of Turin. We would like to acknowledge the contributors to the design and conduct of the SETIL study: Antonio Acquaviva, AOU di Siena, Siena, Italia; Daniele Andreuccetti, I.R.O.E.—CNR— Firenze, Italia; Laura Anglesio, ARPA—Ivrea (To), Italia; Maurizio Aricò, AOU Meyer, Firenze, Italia; Giorgio Assennato, ARPA—Puglia, Bari, Italia; Francesco Barone Adesi, CPO Piemonte, Torino, Italia; Isabella Belletti, National Cancer Institute, Milano, Italia; Gabriella Bernini, AOU Meyer, Firenze, Italia; Marinella Bertolotti, CPO Piemonte, Torino, Italia; Paolo Bevitori, ARPA Rimini, Rimini, Italia; Renzo Biancotto, ARPAV—Venezia, Italia; Pierfranco Biddau, Ospedale Microcitemico, Cagliari, Italia; Annibale Biggeri, Univer-sità degli Studi di Firenze, Firenze, Italia; Luigi Bisanti, ASL di Milano, Milano, Italia; Vittorio Bocchini, Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia; Francesco Bochicchio, Istituto Superiore di Sanità, Roma, Italia; Silvia Bucci, ARPAT, Firenze, Italia; Roberto Calisti, SPreSAL, Civitanova Marche, Italia; Santina Cannizzaro, Lega Italiana per la Lotta contro i Tumori Onlus, Ragusa, Italia; Nicola Caranci, Agenzia sanitaria e sociale regionale, Emilia-Romagna, Bologna, Italia; Veronica Casotto, IRCCS Burlo Garofolo, Trieste, Italia; Fulvio Cavariani, Centro Regionale Amianto, Viterbo, Italia; Egidio Celentano, ARSAN—Agenzia Regionale Sanitaria della Campania, Napoli, Italia; Manuela Chiavarini, Università degli Studi di Perugia, Perugia, Italia; Pierluigi Cocco, Università di Cagliari, Cagliari, Italia; Pietro Comba, Istituto Superiore di Sanità, Roma, Italia; Paolo Crosignani, Istituto Nazionale Tumori, Milano, Italia; Marina Cuttini, Ospedale Pediatrico Bambino Gesù, Roma, Italia; Giovanni d’Amore, ARPA, Ivrea (To), Italia; Gigliola de Nichilo, SPESAL, Barletta, Italia; Gian Luca De Salvo, Istituto Oncologico Veneto IRCCS, Padova, Italia; Elena Duglio, IRCCS AOU San Martino-ITS, IST Genova, Italia; Myris Erna, PMP Fisica, Padova, Italia; Daniela Ferrante, CPO Piemonte, Novara, Italia; Francesco Forastiere, Dipartimento Epidemiologia Regione Lazio, Roma, Italia; Lorenzo Gafà, Lega Italiana per la Lotta contro i Tumori Onlus, Ragusa, Italia; Claudia Galassi, AOU S.Giovanni Battista e CPO Piemonte, Torino, Italia; Luigi Gelli, Struttura Regionale dell’Aut-orità Ambientale, Regione Campania, Napoli, Italia; Marco Gilard-etti, CPO Piemonte, Torino, Italia; Erni Guarino, Istituto Nazionale Tumori, Napoli, Italia; Paolo Guidotti, ITI, Firenze, Italia; Riccardo Haupt, Istituto Giannina Gaslini, Genova, Italia; Ursula Kirchmayer, Dipartimento Epidemiologia Regione Lazio, Roma, Italia; Susanna Lagorio, National Institute of Health, Rome, Italia; Alma Lippi, AOU Meyer, Firenze, Italia; Franco Locatelli, Università di Pavia, Pavia, Italia; Mirti Lombardi, PMP, Ancona, Italia; Dana Loomis, University of North Carolina—USA; Lia Lidia Luzzatto, ASL 1—Torino, Torino, Italia; Mauro Magnoni, ARPA—Ivrea (To), Italia; Giuseppe Masera, Università Milano Bicocca, Monza, Italia; Pia Massaglia, Neuropsichiatria Infantile, Torino, Italia; Franco Merletti, Università di Torino, Torino, Italia; Domenico Franco Merlo, IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, Genova, Italia; Giuseppe Miceli, Azienda Sanitaria Locale.7, Ragusa, Italia; Paola Michelozzi, Dipartimento Epi-demiologia Regione Lazio, Roma, Italia; Liliana Minelli, Università degli Studi di Perugia, Perugia, Italia; Daniele Monetti, Istituto On-cologico Veneto IRCCS, Padova, Italia; Paola Mosciatti, Università di Camerino, Camerino, Italia; Alessandra Greco, Istituto Oncologico Veneto IRCCS, Padova, Italia; Piero Mozzo, Centro Radioattività
PY - 2014/6
Y1 - 2014/6
N2 - Purpose: Tobacco smoke could cause childhood acute lymphoblastic leukemia (ALL) through at least three pathways: (1) prenatal parental smoking; (2) fetal exposure through maternal smoking during pregnancy; and (3) childhood exposure to secondhand smoke (SHS). We tested these hypotheses in a large population-based case-control study (SETIL) primarily designed to evaluate the role of electromagnetic fields in childhood hematopoietic malignancies. Methods: From 1998 to 2003, we enrolled 602 incident cases of ALL from 14 Italian Regions, and 918 controls were individually matched by birthdate, sex, and area of residence. Cases (n = 557) and controls (n = 855) with complete information were analyzed; odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated with logistic regression models conditioned on matching variables and adjusted by birth order, birthweight, duration of breastfeeding, parental age at delivery, education, and occupational exposure to benzene. Results: No evidence associating paternal smoking in the conception period or maternal smoking during the pregnancy with ALL was found. An association of ALL with maternal exposure to SHS during pregnancy (adjusted OR for mothers exposed more than 4 h/day = 2.18, 95 % CI 1.39-3.42) was observed, but recall bias cannot be excluded. Exposure of the children to SHS was associated with ALL only in unadjusted analysis (unadjusted OR for highly exposed children = 1.64; 95 % CI 1.10-2.45). Conclusions: This study does not support the hypothesis that parental active smoking is associated with ALL. We found very weak evidence of increased risk of ALL for children exposed to SHS. Maternal exposure to SHS was associated with ALL, but recall bias is likely to inflate our estimates.
AB - Purpose: Tobacco smoke could cause childhood acute lymphoblastic leukemia (ALL) through at least three pathways: (1) prenatal parental smoking; (2) fetal exposure through maternal smoking during pregnancy; and (3) childhood exposure to secondhand smoke (SHS). We tested these hypotheses in a large population-based case-control study (SETIL) primarily designed to evaluate the role of electromagnetic fields in childhood hematopoietic malignancies. Methods: From 1998 to 2003, we enrolled 602 incident cases of ALL from 14 Italian Regions, and 918 controls were individually matched by birthdate, sex, and area of residence. Cases (n = 557) and controls (n = 855) with complete information were analyzed; odds ratios (OR) and 95 % confidence intervals (95 % CI) were estimated with logistic regression models conditioned on matching variables and adjusted by birth order, birthweight, duration of breastfeeding, parental age at delivery, education, and occupational exposure to benzene. Results: No evidence associating paternal smoking in the conception period or maternal smoking during the pregnancy with ALL was found. An association of ALL with maternal exposure to SHS during pregnancy (adjusted OR for mothers exposed more than 4 h/day = 2.18, 95 % CI 1.39-3.42) was observed, but recall bias cannot be excluded. Exposure of the children to SHS was associated with ALL only in unadjusted analysis (unadjusted OR for highly exposed children = 1.64; 95 % CI 1.10-2.45). Conclusions: This study does not support the hypothesis that parental active smoking is associated with ALL. We found very weak evidence of increased risk of ALL for children exposed to SHS. Maternal exposure to SHS was associated with ALL, but recall bias is likely to inflate our estimates.
KW - Case-control studies
KW - Leukemia, lymphoid
KW - Prenatal exposure delayed effects
KW - Tobacco smoke pollution
UR - http://www.scopus.com/inward/record.url?scp=84901246037&partnerID=8YFLogxK
U2 - 10.1007/s10552-014-0371-9
DO - 10.1007/s10552-014-0371-9
M3 - Article
SN - 0957-5243
VL - 25
SP - 683
EP - 692
JO - Cancer Causes and Control
JF - Cancer Causes and Control
IS - 6
ER -